Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study (Q43753628)

26 November 2017

Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study (English)

1 reference

26 November 2017

Hong Li

1

1 reference

26 November 2017

Ren-Jie Zhou

series ordinal

2

1 reference

26 November 2017

Guo-Qiang Zhang

series ordinal

3

1 reference

26 November 2017

Jian-Ping Xu

series ordinal

4

1 reference

26 November 2017

8 March 2013

1 reference

26 November 2017

1 reference

26 November 2017

34

1 reference

26 November 2017

3

1 reference

26 November 2017

1807-1812

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-0720-4

26 November 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

The Role of RUNX2 in Osteosarcoma Oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Runx2 in normal tissues and cancer cells: A developing story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Biomechanical stimulation of osteoblast gene expression requires phosphorylation of the RUNX2 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0720-4

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23471668

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chemoprevention of lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23471668

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23471668

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-0720-4

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference